Jeff Turner. "Lit Match" 9/7/08 via flickr. Creative Commons Attribution License.
Genetic engineering as a general topic has always raised
controversy over its innate premise of humans “playing god.” This specific controversy narrows genetic
engineering down to the altering of the DNA of human embryos through a process
known as mitochondrial replacement.
Governments have debated over whether or not to allow their scientists
to research this human DNA experimentation, and the United States’ debate has
been highly relevant as of late.
After holding a meeting in 2015 about the ethics of mitochondrial
replacement, the FDA (U.S. Food and Drug Administration) requested that the
National Academies of Sciences, Engineering, and Medicine assemble a team to
address the question of whether or not it is ethical to perform mitochondrial
replacement experiments on humans.
The specific moment that has resurged the debate of genetic
experimentation was when the panel from the Nation Academies responded to the
FDA’s request and published a lengthy report detailing the ethical, social, and
policy issues that mitochondrial replacement raises. This highly qualified panel concluded it is
indeed ethical to allow scientists to perform such DNA transplants on humans
because of the beneficial results that mitochondria replacement can have on
young children whose natural genes would have given them a poor life.
The publication of this report has brought genetic engineering
into the spotlight, and has put the pressure on the FDA and the United States
Congress to permit the research/experiments or not. The controversy will continue up to and after
the FDA comes out with a decision regarding this genetic experimentation.
No comments:
Post a Comment